ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

ZIMV ZimVie Inc

16.82
0.17 (1.02%)
Fuera de horario
Última actualización: 16:30:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
ZimVie Inc ZIMV NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.17 1.02% 16.82 16:30:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
16.64 16.36 16.98 16.82 16.65
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
08/5/202415:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202415:11EDGAR2Form 8-K - Current report
08/5/202415:05GLOBEZimVie Reports First Quarter 2024 Financial Results
24/4/202415:05GLOBEZimVie to Report First Quarter Financial Results on May 8,..
01/4/202407:00GLOBEZimVie Announces Closing of Sale of Spine Business
27/3/202407:00GLOBEZimVie to Participate in the 23rd Annual Needham Virtual..
11/3/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202416:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202416:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/3/202416:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202415:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202419:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28/2/202415:10EDGAR2Form 8-K - Current report
28/2/202415:05GLOBEZimVie Reports Fourth Quarter and Full Year 2023 Financial..
27/2/202415:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202415:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202416:00GLOBEZimVie to Report Fourth Quarter and Full-Year 2023 Financial..
14/2/202414:59EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202414:09EDGAR2Form SC 13G - Statement of acquisition of beneficial..
07/2/202415:05GLOBEZimVie Announces Launch of Next-Generation TSX® Implant in..
02/1/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202416:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202416:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202315:15EDGAR2Form 8-K - Current report
18/12/202307:20EDGAR2Form 8-K - Current report
18/12/202307:00GLOBEZimVie Announces Definitive Agreement to Sell Spine Business..
12/12/202307:00GLOBEZimVie Announces Compatibility Between its Vital™ Spinal..
01/11/202315:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202315:11EDGAR2Form 8-K - Current report
01/11/202315:05GLOBEZimVie Reports Third Quarter 2023 Financial Results and..
31/10/202307:00GLOBEZimVie Announces First U.S. Surgery with the 4.5mm Mobi-C®..
24/10/202307:00GLOBEZimVie Announces Over 2,000 Children Have Received The..
17/10/202307:30GLOBEZimVie Announces the Launch of Azure™ Multi-Platform Product..
11/10/202315:05GLOBEZimVie to Report Third Quarter 2023 Financial Results on..
10/10/202307:30GLOBEZimVie Announces the Recent Launch of Biotivity™ A/C Plus..
03/10/202315:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202307:00GLOBEZimVie Announces FDA Approval to Launch Mobi-C® Hybrid Study
17/8/202307:00GLOBEZimVie Expands Development Cooperation Agreement with..
10/8/202307:00GLOBEZimVie Announces FDA Approval for New Mobi-C® Implant
03/8/202315:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
02/8/202315:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202315:10EDGAR2Form 8-K - Current report
02/8/202315:05GLOBEZimVie Reports Second Quarter 2023 Financial Results and..
12/7/202315:05GLOBEZimVie to Report Second Quarter 2023 Financial Results on..
05/7/202316:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202316:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

Delayed Upgrade Clock